ARTV logo

ARTV

Artiva Biotherapeutics, Inc.NASDAQHealthcare
$6.74-0.15%ClosedMarket Cap: $166.6M

As of 2026-04-06

Insider Statistics (Q1 2026)

Purchases

7

Sales

4

Buy/Sell Ratio

1.75

Total Bought

$0.00

Total Sold

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue Mar 10Huston Thad Allenofficer: Chief Financial OfficerSell220,000$0.00220,000
Tue Feb 24Huston Thad AllenSell0$0.000
Thu Feb 19Sorg Elaine K.directorSell27,500$4.1527,500
Thu Feb 19Sorg Elaine K.Sell0$0.000
Wed Feb 18Raymon Heatherofficer: SVP, Research and DevelopmentSell46,000$0.00152,844
Wed Feb 18Raymon Heatherofficer: SVP, Research and DevelopmentSell1,521$4.00151,323
Wed Feb 18Horan Christopherofficer: Chief Tech Operations OfficerSell117,300$0.00302,639
Wed Feb 18Horan Christopherofficer: Chief Tech Operations OfficerSell2,187$4.00300,452
Wed Feb 18Bush Jenniferofficer: COO, CLO, Secy, Compliance OffSell117,300$0.00350,225
Wed Feb 18Bush Jenniferofficer: COO, CLO, Secy, Compliance OffSell3,515$4.00346,710